oncology

News in brief: Tocilizumab helps manage irAEs in ICI-treated cancer patients; Specialist picked to lead new Medicare review; COVID-19 vax link to menstrual changes should be investigated

Tocilizumab helps manage irAEs in ICI-treated cancer patients Tocilizumab could help cancer patients manage immune-related adverse events (irAEs) and prevent flares of pre-existing auto-immune disorders, according to an Australian-led study. The study assessed tocilizumab’s efficacy in 22 advanced melanoma patients treated with immune checkpoint inhibitors between 2017 and 2021.  It found the anti-interleukin-6 receptor monoclonal ...

Already a member?

Login to keep reading.


OR
© 2022 the limbic